©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Crit Care Med. Feb 4, 2017; 6(1): 13-20
Published online Feb 4, 2017. doi: 10.5492/wjccm.v6.i1.13
Published online Feb 4, 2017. doi: 10.5492/wjccm.v6.i1.13
Management of parenteral nutrition in critically ill patients
Paolo Cotogni, Department of Anesthesia and Intensive Care, Pain Management and Palliative Care, S. Giovanni Battista Hospital, University of Turin, 10123 Turin, Italy
Author contributions: Cotogni P developed the research question and review design, drafted and finalized the manuscript.
Conflict-of-interest statement: The author declares no conflict of interests for this article.
Correspondence to: Paolo Cotogni, MD, MSc, Department of Anesthesia and Intensive Care, Pain Management and Palliative Care, S. Giovanni Battista Hospital, University of Turin, Via Giovanni Giolitti 9, 10123 Turin, Italy. paolo.cotogni@unito.it
Telephone: +39-011-5171634 Fax: +39-011-5171634
Received: September 3, 2016
Peer-review started: September 7, 2016
First decision: September 29, 2016
Revised: October 30, 2016
Accepted: December 7, 2016
Article in press: December 9, 2016
Published online: February 4, 2017
Processing time: 141 Days and 14.9 Hours
Peer-review started: September 7, 2016
First decision: September 29, 2016
Revised: October 30, 2016
Accepted: December 7, 2016
Article in press: December 9, 2016
Published online: February 4, 2017
Processing time: 141 Days and 14.9 Hours
Core Tip
Core tip: The goal of parenteral nutrition (PN) is to complete the therapy without complications. But the goal of “near zero” PN-related complications is achievable if appropriate prevention and monitoring procedures for reducing PN complications are instituted. The key message of this review is the strong recommendation for the development and implementation of protocols for the safe management of PN in critically ill patients, in which each healthcare professional will be actively engaged. If accurately managed, PN can be safely provided for most critically ill patients without expecting a relevant incidence of PN-related complications.